drugset / Trial / NCT00160511
A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)
RandomizedParallel-groupDouble-blind
Summary
16 week trial assessing the efficacy, safety, and tolerability of levetiracetam compared with placebo in the treatment of postherpetic neuralgia.
Timeline
- Start
- 2004-04
- Primary completion
- 2005-08
- Completion
- 2005-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levetiracetam | Other / unclassified | 1000 mg | — |
| Subject | Levetiracetam | Other / unclassified | 3000 mg | — |